AROUND 900,000 Brits are currently living with dementia.
And with an ageing population it’s likely that number will continue to rise, as getting older is the biggest risk factor for the brain robbing disease.
Dementia is one of the leading causes of death globally, bringing with it pain and suffering to both those who have it and those around them.
A new drug, named donanemab, has been proven to slow the disease – heralding a new era where it could become treatable.
The potentially game-changing drug is still in its trial phase, so until it becomes readily available catching the disease early promises the best outcomes.